Product Information
LEUPROLIDE 2WK 14 MG/2.8 ML KT is a generic product labeled by NorthStar Rx LLC, priced at $205.7080 per EA under NDC 72603034401. Its NADAC has been published 95 times since Jul 10, 2024.
Manufacturer
NorthStar Rx LLCNDC
72603034401
Classification
Generic
Dosage Form
KIT
Route
SUBCUTANEOUS
Last Updated
4/22/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA213829On Market Since
3/1/2024
Price Statistics
The NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has been published 95 times since Jul 10, 2024, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $205.7080 per EA |
|---|---|
| All-time high | $301.8717 (Sep 10, 2025) |
| All-time low | $205.7080 (Apr 22, 2026) |
| 52-week high | $301.8717 |
| 52-week low | $205.7080 |
| Median price | $261.3184 |
| Average price | $265.9364 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 95 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEUPROLIDE 2WK 14 MG/2.8 ML KT?
The current National Average Drug Acquisition Cost (NADAC) for LEUPROLIDE 2WK 14 MG/2.8 ML KT, manufactured by NorthStar Rx LLC, is $205.7080 per EA (NDC 72603034401), effective Apr 29, 2026.
How has the price of LEUPROLIDE 2WK 14 MG/2.8 ML KT changed over time?
Over the history we have for it, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has declined 10.7%. It has been tracked across 95 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Since Jul 10, 2024, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has ranged from a low of $205.7080 (Apr 22, 2026) to a high of $301.8717 (Sep 10, 2025), with a median of $261.3184 per EA.
Are there cheaper alternatives to LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEUPROLIDE 2WK 14 MG/2.8 ML KT, is $197.6060 per EA — about 4% below LEUPROLIDE 2WK 14 MG/2.8 ML KT.
Who manufactures LEUPROLIDE 2WK 14 MG/2.8 ML KT?
LEUPROLIDE 2WK 14 MG/2.8 ML KT (NDC 72603034401) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification